Santé log2 分钟
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
After the capital increase, the total nominal value of Bavarian Nordic A/S' share capital is DKK 788,548,570, which is made up of 78,854,857 shares of a nominal value of DKK 10 each, corresponding to ...
Santé log2 分钟
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial ...
ZUG, Switzerland, Nov. 29, 2024 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares.
Santé log2 分钟
Rakovina Therapeutics Announces Increase in Private Placement Offering to $2.5 Million
Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response ...
Santé log2 分钟
Fate Therapeutics Announces Leadership Transition
Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN DIEGO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc.